The University of Chicago Header Logo

Connection

Sangeeta Bhorade to Humans

This is a "connection" page, showing publications Sangeeta Bhorade has written about Humans.
Connection Strength

0.526
  1. Frailty and aging-associated syndromes in lung transplant candidates and recipients. Am J Transplant. 2021 06; 21(6):2018-2024.
    View in: PubMed
    Score: 0.026
  2. Lung transplantation in scleroderma: recent advances and lessons. Curr Opin Rheumatol. 2018 11; 30(6):562-569.
    View in: PubMed
    Score: 0.022
  3. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation. PLoS One. 2014; 9(7):e103643.
    View in: PubMed
    Score: 0.017
  4. The lung microbiome after lung transplantation. Expert Rev Respir Med. 2014 Apr; 8(2):221-31.
    View in: PubMed
    Score: 0.016
  5. Invited commentary. Ann Thorac Surg. 2014 Jan; 97(1):274-5.
    View in: PubMed
    Score: 0.016
  6. Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest. 2013 Jun; 143(6):1717-1724.
    View in: PubMed
    Score: 0.015
  7. Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation. J Heart Lung Transplant. 2013 Jul; 32(7):701-6.
    View in: PubMed
    Score: 0.015
  8. A longitudinal study of patients' symptoms before and during the first year after lung transplantation. Clin Transplant. 2012 Nov-Dec; 26(6):E576-89.
    View in: PubMed
    Score: 0.015
  9. Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation. J Heart Lung Transplant. 2011 Feb; 30(2):175-81.
    View in: PubMed
    Score: 0.013
  10. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation. 2010 Sep 15; 90(5):540-6.
    View in: PubMed
    Score: 0.013
  11. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. Am J Respir Crit Care Med. 2011 Feb 01; 183(3):379-87.
    View in: PubMed
    Score: 0.013
  12. Current trends in immunosuppression for lung transplantation. Semin Respir Crit Care Med. 2010 Apr; 31(2):172-8.
    View in: PubMed
    Score: 0.012
  13. Immunosuppression for lung transplantation. Proc Am Thorac Soc. 2009 Jan 15; 6(1):47-53.
    View in: PubMed
    Score: 0.011
  14. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant. 2008 Sep; 27(9):990-4.
    View in: PubMed
    Score: 0.011
  15. Elevation of interleukin-15 protein expression in bronchoalveolar fluid in acute lung allograft rejection. Chest. 2007 Feb; 131(2):533-8.
    View in: PubMed
    Score: 0.010
  16. Evolving immunosuppressive regimens for lung transplant recipients. Semin Respir Crit Care Med. 2006 Oct; 27(5):470-9.
    View in: PubMed
    Score: 0.010
  17. Sequential gene expression profiling in lung transplant recipients with chronic rejection. Chest. 2006 Sep; 130(3):847-54.
    View in: PubMed
    Score: 0.010
  18. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus. J Heart Lung Transplant. 2005 Apr; 24(4):421-5.
    View in: PubMed
    Score: 0.009
  19. Lung transplantation for interstitial lung disease. Clin Chest Med. 2004 Dec; 25(4):773-82, vii-viii.
    View in: PubMed
    Score: 0.008
  20. Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. Am J Transplant. 2003 Dec; 3(12):1570-5.
    View in: PubMed
    Score: 0.008
  21. The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease. J Am Soc Nephrol. 2023 12 01; 34(12):2039-2050.
    View in: PubMed
    Score: 0.008
  22. Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients. J Heart Lung Transplant. 2002 Dec; 21(12):1274-82.
    View in: PubMed
    Score: 0.007
  23. Clinical validation and utility of Percepta GSC for the evaluation of lung cancer. PLoS One. 2022; 17(7):e0268567.
    View in: PubMed
    Score: 0.007
  24. The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2022 06; 19(6):916-924.
    View in: PubMed
    Score: 0.007
  25. Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study. BMC Pulm Med. 2022 Jan 06; 22(1):26.
    View in: PubMed
    Score: 0.007
  26. Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients. J Heart Lung Transplant. 2001 Sep; 20(9):928-34.
    View in: PubMed
    Score: 0.007
  27. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements. J Heart Lung Transplant. 2021 11; 40(11):1251-1266.
    View in: PubMed
    Score: 0.007
  28. Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia. Am J Respir Crit Care Med. 2021 01 15; 203(2):211-220.
    View in: PubMed
    Score: 0.006
  29. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000 Dec; 19(12):1199-204.
    View in: PubMed
    Score: 0.006
  30. Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study. Chest. 2021 01; 159(1):401-412.
    View in: PubMed
    Score: 0.006
  31. A Molecular Classifier That Identifies Usual Interstitial Pneumonia in Transbronchial Biopsy Specimens of Patients With Interstitial Lung Disease. Chest. 2020 05; 157(5):1391-1392.
    View in: PubMed
    Score: 0.006
  32. Recognition and Management of Myositis-Associated Rapidly Progressive Interstitial Lung Disease. Chest. 2020 07; 158(1):252-263.
    View in: PubMed
    Score: 0.006
  33. Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 06 15; 199(12):1517-1536.
    View in: PubMed
    Score: 0.006
  34. Clinical relevance of lung-restricted antibodies in lung transplantation. Hum Immunol. 2019 Aug; 80(8):595-601.
    View in: PubMed
    Score: 0.006
  35. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest. 1999 Apr; 115(4):1085-91.
    View in: PubMed
    Score: 0.006
  36. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med. 1999 Feb; 159(2):571-9.
    View in: PubMed
    Score: 0.006
  37. Lung transplantation at Loyola University Medical Center. Clin Transpl. 1999; 281-8.
    View in: PubMed
    Score: 0.006
  38. Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant. 2019 04; 19(4):984-994.
    View in: PubMed
    Score: 0.006
  39. Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis. Respir Res. 2018 Nov 26; 19(1):233.
    View in: PubMed
    Score: 0.006
  40. Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis. Cell Metab. 2019 02 05; 29(2):335-347.e5.
    View in: PubMed
    Score: 0.006
  41. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. Am J Respir Crit Care Med. 2018 01 15; 197(2):235-243.
    View in: PubMed
    Score: 0.005
  42. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. Ann Am Thorac Soc. 2017 Oct; 14(10):1514-1522.
    View in: PubMed
    Score: 0.005
  43. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med. 2017 Aug 07; 214(8):2387-2404.
    View in: PubMed
    Score: 0.005
  44. SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis. FASEB J. 2017 06; 31(6):2520-2532.
    View in: PubMed
    Score: 0.005
  45. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. J Heart Lung Transplant. 2016 Apr; 35(4):500-507.
    View in: PubMed
    Score: 0.005
  46. Flow Cytometry Reveals Similarities Between Lung Macrophages in Humans and Mice. Am J Respir Cell Mol Biol. 2016 Jan; 54(1):147-9.
    View in: PubMed
    Score: 0.005
  47. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk. Am J Transplant. 2016 Mar; 16(3):833-40.
    View in: PubMed
    Score: 0.005
  48. Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med. 2015 Apr 22; 7(284):284re3.
    View in: PubMed
    Score: 0.004
  49. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. Am J Transplant. 2015 Aug; 15(8):2188-96.
    View in: PubMed
    Score: 0.004
  50. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey. J Heart Lung Transplant. 2015 Jan; 34(1):65-74.
    View in: PubMed
    Score: 0.004
  51. Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1564-7.
    View in: PubMed
    Score: 0.004
  52. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. Am J Respir Crit Care Med. 2014 Mar 01; 189(5):567-75.
    View in: PubMed
    Score: 0.004
  53. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. Am J Transplant. 2014 Feb; 14(2):446-52.
    View in: PubMed
    Score: 0.004
  54. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest. 2013 Aug; 144(2):616-622.
    View in: PubMed
    Score: 0.004
  55. A novel p38 mitogen-activated protein kinase/Elk-1 transcription factor-dependent molecular mechanism underlying abnormal endothelial cell proliferation in plexogenic pulmonary arterial hypertension. J Biol Chem. 2013 Sep 06; 288(36):25701-25716.
    View in: PubMed
    Score: 0.004
  56. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013 Mar 01; 187(5):527-34.
    View in: PubMed
    Score: 0.004
  57. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One. 2012; 7(12):e51932.
    View in: PubMed
    Score: 0.004
  58. Executive summary: monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Nov; 142(5):1284-1288.
    View in: PubMed
    Score: 0.004
  59. Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Nov; 142(5):e1S-e111S.
    View in: PubMed
    Score: 0.004
  60. SaLUTaRy: survey of lung transplant rejection. J Heart Lung Transplant. 2012 Sep; 31(9):972-9.
    View in: PubMed
    Score: 0.004
  61. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):546-52.
    View in: PubMed
    Score: 0.004
  62. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant. 2012 Sep; 31(9):942-9.
    View in: PubMed
    Score: 0.004
  63. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med. 2011 Nov 01; 184(9):1055-61.
    View in: PubMed
    Score: 0.003
  64. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. Am J Transplant. 2011 Nov; 11(11):2517-22.
    View in: PubMed
    Score: 0.003
  65. Conventional and novel approaches to immunosuppression. Clin Chest Med. 2011 Jun; 32(2):265-77.
    View in: PubMed
    Score: 0.003
  66. Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine. Respir Res. 2011 Apr 10; 12:44.
    View in: PubMed
    Score: 0.003
  67. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. Chest. 2011 Aug; 140(2):489-496.
    View in: PubMed
    Score: 0.003
  68. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant. 2011 Mar; 11(3):561-7.
    View in: PubMed
    Score: 0.003
  69. Early readmission is a predictor of overall survival following isolated lung transplantation. Int Surg. 2010 Oct-Dec; 95(4):299-304.
    View in: PubMed
    Score: 0.003
  70. Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-beta. Am J Respir Cell Mol Biol. 2009 Sep; 41(3):332-8.
    View in: PubMed
    Score: 0.003
  71. Clinical pathway after lung transplantation shortens hospital length of stay without affecting outcome. Int Surg. 2007 Mar-Apr; 92(2):93-8.
    View in: PubMed
    Score: 0.002
  72. Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts. Virol J. 2006 Jan 12; 3:4.
    View in: PubMed
    Score: 0.002
  73. Thoracic organ transplantation in the United States, 1995-2004. Am J Transplant. 2006; 6(5 Pt 2):1188-97.
    View in: PubMed
    Score: 0.002
  74. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients. J Infect Dis. 2002 Sep 15; 186(6):760-8.
    View in: PubMed
    Score: 0.002
  75. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation. 2001 Mar 27; 71(6):773-7.
    View in: PubMed
    Score: 0.002
  76. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med. 2000 May; 161(5):1443-9.
    View in: PubMed
    Score: 0.002
  77. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant. 2000; 5(3):44-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.